Preconditioning protects the heart in a prolonged uremic condition
Open Access
- 15 November 2012
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 303 (10), H1229-H1236
- https://doi.org/10.1152/ajpheart.00379.2012
Abstract
Metabolic diseases such as hyperlipidemia and diabetes attenuate the cardioprotective effect of ischemic preconditioning. In the present study, we examined whether another metabolic disease, prolonged uremia, affects ischemia/reperfusion injury and cardioprotection by ischemic preconditioning. Uremia was induced by partial nephrectomy in male Wistar rats. The development of uremia was verified 29 wk after surgery. Transthoracic echocardiography was performed to monitor cardiac function. At week 30, hearts of nephrectomized and sham-operated rats were isolated and subjected to a 30-min coronary occlusion followed by 120 min reperfusion with or without preceding preconditioning induced by three intermittent cycles of brief ischemia and reperfusion. In nephrectomized rats, plasma uric acid, carbamide, and creatinine as well as urine protein levels were increased as compared with sham-operated controls. Systolic anterior and septal wall thicknesses were increased in nephrectomized rats, suggesting the development of a minimal cardiac hypertrophy. Ejection fraction was decreased and isovolumic relaxation time was shortened in nephrectomized rats demonstrating a mild systolic and diastolic dysfunction. Infarct size was not affected significantly by nephrectomy itself. Ischemic preconditioning significantly decreased infarct size from 24.8 ± 5.2% to 6.6 ± 1.3% in the sham-operated group and also in the uremic group from 35.4 ± 9.5% to 11.9 ± 3.1% of the area at risk. Plasma ANG II and nitrotyrosine were significantly increased in the uremic rats. We conclude that although prolonged experimental uremia leads to severe metabolic changes and the development of a mild myocardial dysfunction, the cardioprotective effect of ischemic preconditioning is still preserved.Keywords
This publication has 57 references indexed in Scilit:
- Ischemic Conditioning Protects the Uremic Heart in a Rodent Model of Myocardial InfarctionCirculation, 2012
- Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia–reperfusion induced infarct sizeCytokine, 2011
- The Role of the Primary Care Physician in Managing Early Stages of Chronic Kidney DiseasePostgraduate Medicine, 2011
- Protecting the Heart From Ischemia: An Update on Ischemic and Pharmacologic ConditioningHospital Practice, 2011
- Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 DiabetesAntioxidants and Redox Signaling, 2011
- Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Failure to precondition pathological human myocardiumJournal of the American College of Cardiology, 2001
- Loss of Pacing-induced Preconditioning in Rat Hearts: Role of Nitric Oxide and Cholesterol-enriched DietJournal of Molecular and Cellular Cardiology, 1997
- Ischaemic preconditioning protects hypertrophied myocardiumCardiovascular Research, 1994